Chelidonium majus L. (Ukrain) in the treatment of cancer patients.

Primary tabs

field_vote: 
Average: 6.3 (3 votes)
Publication type: 
Number of included patients: 
References: 
Therapeutic intervention: 
Disease(s): 
Therapeutic Substance(s): 

Drugs Exp Clin Res. 1992;18 Suppl:73-7.
Chelidonium majus L. (Ukrain) in the treatment of cancer patients.
Lohninger A, Hamler F.
2nd Dept. of Obstetrics and Gynaecology, Vienna Medical School, Austria.

Ukrain, a semi-synthetic thiophosphoric acid compound of alkaloid chelidonine isolated from Chelidonium Majus L., Tris(2-([5bS-(5ba,6b,12ba)]-5b,6,7,12b,13,14- Hexahydro-13-methyl][1,3]-benzodioxolo[5,6-c]-1,3-dioxolo[4, 5- i]phenanthridinium-6-ol]-Ethaneaminyl) Phosphinesulfide 6HCl, causes a regression of tumours and metastases in many oncological patients. More than 400 documented patients with various carcinomas in different stages of development have been treated with Ukrain.
The authors report on one 9 year old girl with "untreatable" Ewing Sarcoma, a 58 year old woman with colon cancer with lymph node metastasis and a 69 year women with breast cancer with skeleton metastasis. All were treated with Ukrain with complete remission lasting at least several years as a result . Ukrain can be helpful in improving the general condition and prolonging life by reduction of the tumour progression and its immunomodulating effect on the organism.